MARKET

ASMB

ASMB

Assembly
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.00
+2.05
+10.28%
After Hours: 22.00 0 0.00% 16:00 06/05 EDT
OPEN
20.54
PREV CLOSE
19.95
HIGH
22.22
LOW
20.13
VOLUME
347.74K
TURNOVER
--
52 WEEK HIGH
25.07
52 WEEK LOW
8.13
MARKET CAP
719.89M
P/E (TTM)
-6.4333
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ASMB stock price target is 42.50 with a high estimate of 74.00 and a low estimate of 30.00.

EPS

ASMB News

More
Assembly Biosciences Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 5d ago
Assembly Biosciences Appoints William Delaney As Chief Scientific Officer
Benzinga · 05/27 12:18
Assembly Biosciences Announces Management Transition
-- Expert Virologist and Biologist William Delaney, PhD joins as Chief Scientific Officer, Virology --  -- EVP and CSO of Virology Operations Richard Colonno, PhD to retire --.
GlobeNewswire · 05/27 12:00
Assembly Biosciences to Present During the Jefferies Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 26, 2020 -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting.
GlobeNewswire · 05/26 12:00
Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020
This change is to protect the safety, health and well-being of its stockholders, directors, employees and the public during the COVID-19 pandemic. Stockholders will not be able to attend the Annual Meeting in person at a physical location. Despite the change
GlobeNewswire · 05/19 20:05
Why Assembly Biosciences (ASMB) Stock Might be a Great Pick
Zacks · 05/15 16:14
Will Assembly Biosciences Continue to Surge Higher?
Zacks · 05/13 15:58
Assembly Biosciences, Inc. (ASMB) Assembly Biosciences' HBV Portfolio Progress Conference Call (Transcript)
Seeking Alpha - Transcript · 05/13 02:51

Industry

Pharmaceuticals
+0.57%
Pharmaceuticals & Medical Research
+0.37%

Hot Stocks

Symbol
Price
%Change

About ASMB

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has discovered various core protein Allosteric Modulators (CpAMs), which are small molecules that directly target and allosterically modulate the HBV core (HBc) protein. Its Microbiome Program consists of an integrated platform that includes a strain identification and selection process, methods for strain isolation and growth under current good manufacturing practice conditions, and a delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal (GI) tract. The lead product candidate from this platform, AB-M101, is in development for the treatment of clostridium difficile-infections.
More

Webull offers kinds of Assembly Biosciences Inc stock information, including NASDAQ:ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions.